Pluri Inc.
Biotechnology firm with 3D cell-expansion tech for manufacturing cell-based products.
PLUR | TA
Overview
Corporate Details
- ISIN(s):
- US72942G2030
- LEI:
- Country:
- Israel
- Address:
- Park Building No. 5, 3508409 Haifa
- Website:
- https://pluri-biotech.com/
- Sector:
- Manufacturing
Description
Pluri Inc. is a biotechnology company specializing in proprietary 3D cell-expansion technology. The company develops and operates platforms for the scalable, consistent, and cost-effective manufacturing of cell-based products. Its technology is applied across multiple sectors, including regenerative medicine, cell therapy, food technology, and agriculture technology (AgTech). Pluri aims to create next-generation cell-based products to improve human wellbeing and establishes partnerships to leverage its platform. The company also provides Contract Development and Manufacturing Organization (CDMO) services.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-07-27 01:34 |
FORM 3-INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF
SECURITIES
|
English | 121.5 KB | ||
| 2021-07-27 01:34 |
FORM 3-INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF
SECURITIES
|
English | 36.0 KB | ||
| 2021-07-19 16:48 |
8k - Appointment of new Directors
|
English | 115.0 KB | ||
| 2021-07-19 16:48 |
8k - Appointment of new Directors
|
English | 37.9 KB | ||
| 2021-07-19 15:59 |
Appoints Prof. Varda Shalev MD and Mr. Doron Birger to Join its Board of Direct…
|
English | 166.0 KB | ||
| 2021-07-19 15:59 |
Appoints Prof. Varda Shalev MD and Mr. Doron Birger to Join its Board of Direct…
|
English | 35.9 KB | ||
| 2021-07-08 16:48 |
FORM 8-K-Brings ARDS Associated by with COVID-19 Phase II Studies to Clinical R…
|
English | 114.5 KB | ||
| 2021-07-08 16:48 |
FORM 8-K-Brings ARDS Associated by with COVID-19 Phase II Studies to Clinical R…
|
English | 38.0 KB | ||
| 2021-07-08 16:09 |
Pluristem Brings ARDS Associated with COVID-19 Phase II Studies to Clinical Rea…
|
English | 168.8 KB | ||
| 2021-07-08 16:09 |
Pluristem Brings ARDS Associated with COVID-19 Phase II Studies to Clinical Rea…
|
English | 35.9 KB | ||
| 2021-06-02 15:55 |
annual shareholders meeting results - June 2, 2021
|
English | 112.1 KB | ||
| 2021-06-02 15:55 |
annual shareholders meeting results - June 2, 2021
|
English | 37.9 KB | ||
| 2021-05-25 16:51 |
8K - first tranche of EIB loan
|
English | 114.9 KB | ||
| 2021-05-25 16:51 |
8K - first tranche of EIB loan
|
English | 37.9 KB | ||
| 2021-05-25 16:00 |
Pluristem to Receive €20M Non-Dilutive Funding from the European Investment Bank
|
English | 171.9 KB |
Automate Your Workflow. Get a real-time feed of all Pluri Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pluri Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pluri Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
